Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P)

od Brown, Justin T, Lahey, Cora, Laosinchai-Wolf, Walairat, Hadd, Andrew G
Wydane 2006

A Dual-Mode Single-Molecule Fluorescence Assay for the Detection of Expanded CGG Repeats in Fragile X Syndrome

od Cannon, Brian, Pan, Cynthia, Chen, Liangjing, Hadd, Andrew G., Russell, Rick
Wydane 2013

The role of AGG interruptions in fragile X repeat expansions: a twenty-year perspective

od Latham, Gary J., Coppinger, Justine, Hadd, Andrew G., Nolin, Sarah L.
Wydane 2014

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

od Houghton, Jeffrey, Hadd, Andrew G., Zeigler, Robert, Haynes, Brian C., Latham, Gary J.
Wydane w J Vis Exp (2016)

Intermediate CGG repeat length at the FMR1 locus is not associated with hormonal indicators of ovarian age

od Kline, Jennie K, Kinney, Ann M, Levin, Bruce, Brown, Stephen A, Hadd, Andrew G, Warburton, Dorothy
Wydane 2014

X-inactivation in the clinical phenotype of fragile X premutation carrier sisters

od Hall, Deborah A., Robertson-Dick, Erin E., O'Keefe, Joan A., Hadd, Andrew G., Zhou, Lili, Berry-Kravis, Elizabeth
Wydane w Neurol Genet (2016)

A methylation PCR method determines FMR1 activation ratios and differentiates premutation allele mosaicism in carrier siblings

od Hadd, Andrew G., Filipovic-Sadic, Stela, Zhou, Lili, Williams, Arianna, Latham, Gary J., Berry-Kravis, Elizabeth, Hall, Deborah A.
Wydane w Clin Epigenetics (2016)

Microsphere Bead Arrays and Sequence Validation of 5/7/9T Genotypes for Multiplex Screening of Cystic Fibrosis Polymorphisms

od Hadd, Andrew G., Laosinchai-Wolf, Walairat, Novak, Chris R., Badgett, Marty R., Isgur, Lesley A., Goldrick, Marianna, WalkerPeach, Cindy R.
Wydane 2004

Validation of Fragile X Screening in the Newborn Population Using a Fit-for-Purpose FMR1 PCR Assay System

od Lee, Stacey, Taylor, Jennifer L., Redmond, Charles, Hadd, Andrew G., Kemppainen, Jon A., Haynes, Brian C., Shone, Scott, Bailey, Donald B., Latham, Gary J.
Wydane w J Mol Diagn (2020)

A Novel Methylation PCR that Offers Standardized Determination of FMR1 Methylation and CGG Repeat Length without Southern Blot Analysis

od Grasso, Marina, Boon, Elles M.J., Filipovic-Sadic, Stela, van Bunderen, Patrick A., Gennaro, Elena, Cao, Ru, Latham, Gary J., Hadd, Andrew G., Coviello, Domenico A.
Wydane 2014

Expansions and contractions of the FMR1 CGG repeat in 5,508 transmissions of normal, intermediate, and premutation alleles

od Nolin, Sarah L., Glicksman, Anne, Tortora, Nicole, Allen, Emily, Macpherson, James, Mila, Montserrat, Vianna‐Morgante, Angela M., Sherman, Stephanie L., Dobkin, Carl, Latham, Gary J., Hadd, Andrew G.
Wydane w Am J Med Genet A (2019)

Absence of AGG Interruptions Is a Risk Factor for Full Mutation Expansion Among Israeli FMR1 Premutation Carriers

od Domniz, Noam, Ries-Levavi, Liat, Cohen, Yoram, Marom-Haham, Lilach, Berkenstadt, Michal, Pras, Elon, Glicksman, Anne, Tortora, Nicole, Latham, Gary J., Hadd, Andrew G., Nolin, Sarah L., Elizur, Shai E.
Wydane w Front Genet (2018)

Fragile X AGG Analysis Provides New Risk Predictions for 45–69 Repeat Alleles

od Nolin, Sarah L., Sah, Sachin, Glicksman, Anne, Sherman, Stephanie L., Allen, Emily, Berry-Kravis, Elizabeth, Tassone, Flora, Yrigollen, Carolyn, Cronister, Amy, Jodah, Marcia, Ersalesi, Nicole, Dobkin, Carl, Brown, W. Ted, Shroff, Raghav, Latham, Gary J., Hadd, Andrew G.
Wydane w Am J Med Genet A (2013)